Cell-Penetrating Phylomers Improve Delivery of Drugs
Filed with ASX · · 2 pages · English
PYC Therapeutics Limited on 6ix
Story so far
Earlier from PYC Therapeutics
- R&D Tax Rebate
- Phylogica Signs Agreement with MedImmune / AstraZeneca
- Phylogica - New Potential For Treating Brain Injury
- Phylogica Accesses Novel Half-Life Extension Technology
- Technology Licence to Janssen Biotech
Later from PYC Therapeutics
- Chief Executive Officer Resignation
- Operational Update
- Shareholder Update
- AGM Presentation to Shareholders
- NHMRC Grant Awarded to Collaborators
Follow PYC Therapeutics into a list and get an email when it puts out news.
Follow PYC Therapeutics